Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum

Dopaminergic (DAergic) influence on ischemie neuronal cell damage in the dorsolateral striatum was studied. Intact and 6-hydroxydopamine (6-OHDA) lesioned rats, with and without pretreatment by D 1 and D 2 DA antagonists, were subjected to 20 min forebrain ischemia. Extracellular DA and glutamate (G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research bulletin 1994, Vol.33 (3), p.281-288
Hauptverfasser: Hashimoto, Nobukazu, Matsumoto, Takashi, Abe, Hideo M., Hashitani, Takeshi, Nishino, Hitoo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dopaminergic (DAergic) influence on ischemie neuronal cell damage in the dorsolateral striatum was studied. Intact and 6-hydroxydopamine (6-OHDA) lesioned rats, with and without pretreatment by D 1 and D 2 DA antagonists, were subjected to 20 min forebrain ischemia. Extracellular DA and glutamate (Glu) were measured using microdialysis technique. Histological examination was performed on the dorsolateral striatum and the hippocampal CA1 area 24 h after ischemia. DA increased 400–500 times the control level during ischemia among the groups except the 6-OHDA lesioned group. No significant changes were observed in the concentration of 3,4-dihydroxyphenylacetic acid (DOPAC), but a transient decrease was seen in homovanillic acid (HVA). Due to ischemia, Glu increased up to about 5 times the control level among the groups. Neuronal damage in the dorsolateral striatum was slightly attenuated by 6-OHDA lesion. Treatment by spiperone (D 2 antagonist, 7 μg/kg IP) alone attenuated the damage strongly. Treatment by SCH23390 (D 1 antagonist, 2.5 mg/kg IP) alone or both D 1 and D 2 antagonists had no effects. Data suggest that excessive Glu and DA are involved in neuronal cell damage. DA might enhance the damage via D 2 but inhibit via D 1 receptor.
ISSN:0361-9230
1873-2747
DOI:10.1016/0361-9230(94)90195-3